Improving early diagnosis of bronchopulmonary dysplasia.
Expert Rev Respir Med
; 18(5): 283-294, 2024 May.
Article
de En
| MEDLINE
| ID: mdl-38875260
ABSTRACT
INTRODUCTION:
Bronchopulmonary disease (BPD) is associated with long-term neurodevelopmental and cardiorespiratory complications, often requiring significant use of resources. To reduce this healthcare burden, it is essential that those at high risk of BPD are identified early so that strategies are introduced to prevent disease progression. Our aim was to discuss potential methods for improving early diagnosis in the first week after birth. AREAS COVERED A narrative review was undertaken. The search strategy involved searching PubMed, Embase and Cochrane databases from 1967 to 2024. The results of potential biomarkers and imaging modes are discussed. Furthermore, the value of scoring systems is explored. EXPERT OPINION BPD occurs as a result of disruption to pulmonary vascular and alveolar development, thus abnormal levels of factors regulating those processes are promising avenues to explore with regard to early detection of high-risk infants. Data from twin studies suggests genetic factors can be attributed to 82% of the observed difference in moderate to severe BPD, but large genome-wide studies have yielded conflicting results. Comparative studies are required to determine which biomarker or imaging mode may most accurately diagnose early BPD development. Models which include the most predictive factors should be evaluated going forward.Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Dysplasie bronchopulmonaire
/
Marqueurs biologiques
/
Diagnostic précoce
Limites:
Humans
/
Newborn
Langue:
En
Journal:
Expert Rev Respir Med
Année:
2024
Type de document:
Article
Pays d'affiliation:
Royaume-Uni